Plain-English translation of NCT07003009 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing a new diagnostic imaging technique called immune checkpoint washout to help doctors more accurately detect whether breast cancer has spread to nearby lymph nodes. Currently, doctors rely on physical exams, ultrasound, and sometimes biopsies to check for cancer spread—but these methods aren't always accurate or can take a long time. This study hopes to show that the new imaging method could be faster and more reliable.
Many breast cancer patients need to know whether their cancer has spread to lymph nodes, because this information is critical for planning treatment and predicting outcomes. However, current methods to detect lymph node involvement are either not very accurate (physical exams catch only about 1 in 3 cases) or require uncomfortable biopsies that take weeks to get results. This trial aims to find a faster, more accurate way to give patients answers.
You likely qualify if…
You likely don't qualify if…
If you qualify, you would undergo the new immune checkpoint washout imaging procedure on your lymph nodes. The study will compare results from this new imaging method with results from standard biopsies to see if the new method is accurate. You would likely have imaging done at the hospital, and your results would be carefully tracked and compared with traditional diagnostic methods.
AI-generated summary from trial data · Jun 9, 2026 · Not medical advice
Turkey (Türkiye)